Clinical Study
HEALEY ALS Trial
This study is looking at the safety and effectiveness of four different investigational treatment regimens: Zilucoplan, Verdiperstat, CNM-Au8, and Pridopidine for ALS. Each regimen will have an active investigational product and a matching placebo that will be tested. New regimens will be continuously added as new investigational products become available.
For more information contact:
Crystal Neate
crystal.neate@hsc.utah.edu
8015813367
IRB#: IRB_00143448
| PI: Summer Gibson
| Department: NEUROLOGY
| Approval Date: 2021-09-28 22:37:00
Study Categories: Neurological Studies
| Specialties: Neurology
Who can participate?
Gender: All
Age: Over 18 years old
Volunteers: Volunteers with special conditions
Location: In Person
Will I be paid for my time?
Yes